A Phase 2a Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol as a Steroid-sparing Therapy in Steroid-dependent Crohn's Disease Patients

NCT04056442 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Steroid Dependent Crohn's Disease

Interventions

DRUG: Cannabidiol , synthetic form
DRUG: Placebo

Sponsor

Stero Biotechs Ltd.